146 related articles for article (PubMed ID: 22219230)
1. Q: Should target natriuretic peptide levels be used for outpatient management of chronic heart failure?
Ibrahim A; Baibars M; Alraies MC; Oliveira GH
Cleve Clin J Med; 2012 Jan; 79(1):22-5. PubMed ID: 22219230
[No Abstract] [Full Text] [Related]
2. Biomarker-guided treatment of heart failure: still waiting for a definitive answer.
Troughton RW; Frampton CM; Nicholls MG
J Am Coll Cardiol; 2010 Dec; 56(25):2101-4. PubMed ID: 21144970
[No Abstract] [Full Text] [Related]
3. Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) study.
Eurlings LW; van Pol PE; Kok WE; van Wijk S; Lodewijks-van der Bolt C; Balk AH; Lok DJ; Crijns HJ; van Kraaij DJ; de Jonge N; Meeder JG; Prins M; Pinto YM
J Am Coll Cardiol; 2010 Dec; 56(25):2090-100. PubMed ID: 21144969
[TBL] [Abstract][Full Text] [Related]
4. Correlation between serial measurements of N-terminal pro brain natriuretic peptide and ambulatory cardiac filling pressures in outpatients with chronic heart failure.
Braunschweig F; Fahrleitner-Pammer A; Mangiavacchi M; Ghio S; Fotuhi P; Hoppe UC; Linde C
Eur J Heart Fail; 2006 Dec; 8(8):797-803. PubMed ID: 16716660
[TBL] [Abstract][Full Text] [Related]
5. NT-proBNP and BNP: biomarkers for heart failure management.
Bettencourt P
Eur J Heart Fail; 2004 Mar; 6(3):359-63. PubMed ID: 14987589
[TBL] [Abstract][Full Text] [Related]
6. Natriuretic peptide-guided management of acutely destabilized heart failure: rationale and treatment algorithm.
Bhardwaj A; Januzzi JL
Crit Pathw Cardiol; 2009 Dec; 8(4):146-50. PubMed ID: 19952548
[TBL] [Abstract][Full Text] [Related]
7. Updating the role of natriuretic peptide levels in cardiovascular disease.
Gopal DJ; Iqbal MN; Maisel A
Postgrad Med; 2011 Nov; 123(6):102-13. PubMed ID: 22104459
[TBL] [Abstract][Full Text] [Related]
8. Amino-terminal pro-brain natriuretic peptide: a biomarker for diagnosis, prognosis and management of heart failure.
Morello AM; Januzzi JL
Expert Rev Mol Diagn; 2006 Sep; 6(5):649-62. PubMed ID: 17009901
[TBL] [Abstract][Full Text] [Related]
9. Can B-type natriuretic peptides replace heart failure risk models?
Levy WC
Eur J Heart Fail; 2008 Mar; 10(3):224-5. PubMed ID: 18313983
[No Abstract] [Full Text] [Related]
10. Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center.
Amir O; Paz H; Ammar R; Yaniv N; Schliamser JE; Lewis BS
Isr Med Assoc J; 2008 Feb; 10(2):109-12. PubMed ID: 18432021
[TBL] [Abstract][Full Text] [Related]
11. [Determination of brain natriuretic peptide levels and its N-terminal fragment for the evaluation of renal replacement therapies efficiency in patients with decompensated chronic heart failure].
Tabak'ian EA; Zaruba AIu; Rogoza AN; Ataullakhanova DM; Kukharchuk VV
Ter Arkh; 2010; 82(8):24-9. PubMed ID: 20873241
[TBL] [Abstract][Full Text] [Related]
12. Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
Bhardwaj A; Rehman SU; Mohammed A; Baggish AL; Moore SA; Januzzi JL
Am Heart J; 2010 Apr; 159(4):532-538.e1. PubMed ID: 20362709
[TBL] [Abstract][Full Text] [Related]
13. Circulating natriuretic peptide levels in acute heart failure.
Maisel A
Rev Cardiovasc Med; 2007; 8 Suppl 5():S13-21. PubMed ID: 18192949
[TBL] [Abstract][Full Text] [Related]
14. Amino-terminal pro-B-type natriuretic peptides and prognosis in chronic heart failure.
Masson S; Latini R
Am J Cardiol; 2008 Feb; 101(3A):56-60. PubMed ID: 18243860
[TBL] [Abstract][Full Text] [Related]
15. Natriuretic peptides in heart failure: their role in daily practice.
Loboz-Grudzień K; Jaroch J
Cardiol J; 2009; 16(1):1-3. PubMed ID: 19130409
[No Abstract] [Full Text] [Related]
16. Improving risk stratification for heart failure. A role for serial testing of B-type natriuretic peptides?
Daly MG; Frampton CM; Troughton RW
J Am Coll Cardiol; 2010 Feb; 55(5):451-3. PubMed ID: 20117458
[No Abstract] [Full Text] [Related]
17. Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: a direct comparison of N-terminal atrial natriuretic peptide, N-terminal brain natriuretic peptide and brain natriuretic peptide.
Hülsmann M; Berger R; Mörtl D; Gore O; Meyer B; Pacher R
Eur J Heart Fail; 2005 Jun; 7(4):552-6. PubMed ID: 15921794
[TBL] [Abstract][Full Text] [Related]
18. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
Green SM; Green JA; Januzzi JL
Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
[TBL] [Abstract][Full Text] [Related]
19. Outpatient monitoring and treatment of chronic heart failure guided by amino-terminal pro-B-type natriuretic peptide measurement.
Troughton RW; Richards AM
Am J Cardiol; 2008 Feb; 101(3A):72-5. PubMed ID: 18243863
[TBL] [Abstract][Full Text] [Related]
20. The clinical role of natriuretic peptides--importance of BNP and NT-proBNP. Implications in heart failure and acute coronary syndrome.
Machado M; Falcão LM; Ravara L
Rev Port Cardiol; 2004; 23(7-8):1005-32. PubMed ID: 15478326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
